Meta‐analysis: effect of hormone‐replacement therapy on components of the metabolic syndrome in postmenopausal women

@article{Salpeter2006MetaanalysisEO,
  title={Meta‐analysis: effect of hormone‐replacement therapy on components of the metabolic syndrome in postmenopausal women},
  author={S Salpeter and Judith M. E. Walsh and Thomas M. Ormiston and Elizabeth Greyber and Nicholas S. Buckley and Edwin Salpeter},
  journal={Diabetes},
  year={2006},
  volume={8}
}
Aim:  To quantify the effects of hormone‐replacement therapy (HRT) on components of the metabolic syndrome in postmenopausal women. 
Effect of metformin on cardiovascular risk factors in middle‐aged Thai women with metabolic syndrome: A randomized placebo‐controlled trial
TLDR
To evaluate the effect of metformin on cardiovascular risk factors in middle‐aged Thai women with metabolic syndrome that are in menopausal transition, a large number of women have metabolic syndrome and the risk of heart attack is high. Expand
Cardiometabolic disorders and menopausal hormone therapy
TLDR
The role of endo- and exogenous estrogens and androgens in the genesis of cardiometabolic disorders in postmenopausal women and the role of menopausal hormone therapy in their prevention is highlighted. Expand
EFFECT OF 15 WEEKS COMBINATION EXERCISE TRAINING ON LIPID PROFILE AND FATTY LIVER INDICES IN POSTMENOPAUSAL WOMEN WITH BREAST CANCER
TLDR
The aim of this study was to clarify the effect of 15 weeks combination exercise training on lipid profile and fatty liver indices in postmenopausal women and to establish a protocol for this type of treatment. Expand
Postmenopausal Hormone Therapy: The Heart of the Matter
In this issue, the USPSTF recommends against using hormone therapy for the prevention of chronic conditions in postmenopausal women. The editorialists discuss why evidence that became available aft...
MENOPAUSAL HORMONE THERAPY AND NEW-ONSET DIABETES IN THE FRENCH E 3 N COHORT
Aims/hypothesis. Two US randomized trials found a lower incidence of type 2 diabetes among women treated by menopausal hormone therapy (MHT) with oral conjugated equine estrogen combined withExpand
Effect of menopausal hormone therapy on components of the metabolic syndrome
TLDR
The effects of menopause in predisposing to components of metabolic syndrome including visceral obesity, dyslipidemia, type 2 diabetes (T2D) and hypertension (HTN) are summarized. Expand
Endogenous oestradiol as a positive correlate of plasma fibrinogen among older postmenopausal women: a population‐based study (the Three‐City cohort study)
Plasma fibrinogen is a strong predictor of ischaemic arterial disease in women. Sex steroid hormones including hormone therapy may play an important role in the development of cardiovascular disease.Expand
Depressive symptoms predispose females to metabolic syndrome: a 7‐year follow‐up study
TLDR
To evaluate the risk for developing metabolic syndrome when having depressive symptoms, a large number of patients were found to have depressive symptoms but not to have metabolic syndrome. Expand
Postmenopausal estrogen therapy: which route to take?
  • J. Simon
  • Medicine
  • Nature Clinical Practice Endocrinology &Metabolism
  • 2009
TLDR
The author of this Viewpoint compares the pharmacodynamics of oral and nonoral estradiol therapies, and discusses the most important risk factors to consider when using either administration route. Expand
A randomized trial of estrogen or raloxifene during postmenopausal weight loss: Adiposity and cardiometabolic outcomes
TLDR
It was hypothesized that HT or a selective estrogen receptor modulator (raloxifene) would augment reductions in abdominal visceral fat during weight loss when compared to placebo, potentially increasing improvements in glucose tolerance and lipid profile. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 178 REFERENCES
Effect of hormone replacement therapy on cardiovascular risk factors in postmenopausal women with diabetes *
Background:  Hormone replacement therapy (HRT) in postmenopausal women improves menopausal symptoms, decreases the incidence of osteoporotic fracture, but the effects on cardiovascular risk factorsExpand
A placebo‐controlled trial of long‐term oral combined continuous hormone replacement therapy in postmenopausal women: effects on arterial compliance and endothelial function
OBJECTIVE To study the effects of long‐term combined continuous oral hormone replacement therapy (HRT) on vascular function in healthy postmenopausal women.
Efficacy of sequential hormone replacement therapy in the treatment of hypercholesterolemia among postmenopausal women
TLDR
To test the efficacy of hormone replacement therapy and dietary therapy, compared to dietary Therapy, in lowering LDL cholesterol levels among postmenopausal women, and to investigate the role of diet in lowering cholesterol levels. Expand
Differential Effects of Raloxifene and Estrogen on Insulin Sensitivity in Postmenopausal Women
TLDR
The hypothesis that both raloxifene and estrogen would improve insulin sensitivity in postmenopausal women and that the magnitude of the effect would be similar for both drugs is tested. Expand
Metabolic, inflammatory and haemostatic effects of a low‐dose continuous combined HRT in women with type 2 diabetes: potentially safer with respect to vascular risk?
background  Conventional hormone replacement therapy (HRT) containing conjugated equine oestrogen (CEE) and medroxyprogesterone acetate (MPA) increases triglyceride, C‐reactive protein (CRP) andExpand
Effect of combined oral estrogen/progestogen preparation (Kliogest®) on bone mineral density, plasma lipids and postmenopausal symptoms in HRT‐naïve Thai women
TLDR
Kliogest® is commonly prescribed for the relief of acute postmenopausal symptoms and prevention of post menopausal bone loss, but there have been few data on its effect in Asian women. Expand
Effect of oestrogen replacement therapy on serum lipid profile
TLDR
This data indicates that oestrogen deficiency in postmenopausal women alters the lipid metabolism unfavourably and may have implications for women’s physical and mental health. Expand
Hormone replacement therapy and sensitive C-reactive protein concentrations in women with type-2 diabetes
TLDR
A combination of transdermal oestradiol 80 microg with continuous oral norethisterone 1 mg significantly reduced C-reactive protein concentrations in postmenopausal women with type-2 diabetes. Expand
Postmenopausal smokers show reduced hemodynamic benefit from oral hormone replacement.
TLDR
Smokers had significantly less reduction in both resting and stress-induced vascular resistance and blood pressure after treatment with oral hormone replacement therapy than nonsmokers. Expand
Effect of simvastatin on serum C-reactive protein during hormone replacement therapy.
TLDR
It is concluded that statins may reduce the inflammatory adverse effects associated with the CRP increase induced by HRT, and not the combination of HRT and simvastatin. Expand
...
1
2
3
4
5
...